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TO THE EDITOR
Cutaneous T-cell lymphomas (CTCL)
consist of a group of clonal, T-cell
proliferative disorders of skin-trafficking
lymphocytes. Mycosis fungoides (MF)
and Sezary syndrome (SS) are the most
common types of CTCL. The prognosis
of patients with MF or SS is variable
depending upon the extent of skin,
blood, and lymph node involvement
(Girardi et al., 2004). Adult T-cell
leukemia/lymphoma (ATL) is another
form of CTCL, which is characterized
by infection with the retrovirus, human
T lymphotropic virus (HTLV-1).
Although ATL may be clinically indis-
tinguishable from MF or SS, it typically
manifests as an extremely aggressive
lymphoma or leukemia with a poor
prognosis (Siegel et al., 2001).
One of the clinical similarities be-
tween MF, SS, and ATL is the high
incidence of infection associated with
advanced disease. Moreover, opportu-
nistic infections represent a character-
istic clinical feature of patients with
ATL (Bunn et al., 1983). These clinical
observations suggest that host cellular
immunity is impaired. Indeed, substan-
tial laboratory data clearly support the
hypothesis that patients with advanced
forms of CTCL exhibit a profound
depression in cell-mediated immunity
characterized by defects in tissue helper
type 1 cytokine production and cell-
mediated cytotoxicity (Siegel et al.,
2001; Girardi et al., 2004). Another
similarly between MF, SS, and ATL is
that these are typically proliferative
disorders CD4þ T cells. In virtually
all cases of ATL and in many cases of
MF and SS, there is increased expres-
sion of CD25 by the CD4þ population
of T cells. Thus, the peripheral blood
compartment is comprised of an ex-
panded population of CD4þCD25þ T
cells, which is the phenotype expressed
by a major population of regulatory T
cells known to suppress in vivo immune
responses.
While expression of CD25 is often
used as a cell surface marker for
regulatory T-cell subsets, it is also
expressed on the majority of recently
activated T cells, which exhibit no
suppressive capacity. Thus, expression
of the transcription factor Foxp3, which
is both necessary and sufficient for
regulatory function, must be used for
definitive detection of CD4þCD25þ
Tregs (Fontenot et al., 2003; Hori et al.,
2003). A number of groups have
recently established a correlation be-
tween HTLV-1 infection and increased
Foxp3 expression in peripheral blood
mononuclear cells (PBMCs) from ATL
patients (Karube et al., 2004; Yagi et al.,
2004; Matsubara et al., 2005). To
determine whether Foxp3 expression
may also be increased in other CTCL
samples, we screened PBMCs from a
random panel of 15 CTCL patients for
relative expression of Foxp3 using
quantitative real-time PCR. These sam-
ples were also assessed for the presence
of HTLV-1 by conventional PCR and
serological analysis. Donation of blood
by patients and normal volunteers in
this study conformed to Institutional
Review Board-approved protocols and
informed consent was obtained. This
study was performed in accordance
with the Declaration of Helsinki Prin-
ciples.
Of the 15 patients screened, 12
showed no signs of HTLV-1 infection
either by serological testing or PCR
(data not shown). Among these 12, nine
expressed Foxp3 at levels similar to
PBMCs from normal healthy indi-
viduals. The three remaining samples
had varying but significantly increased
levels of Foxp3 ranging from a four- to
nine-fold increase over normal levels.
The reasons for these observed differ-
ences in Foxp3 expression among
HTLV1-negative CTCL patients are un-
clear. However, a recent report by
Berger et al. (2005) has demonstrated
that CTCL-specific CD4þ T cells can
adopt a Treg phenotype upon pro-
longed stimulation with autologous
immature dendritic cells presenting
antigens from apoptotic CTCL tumor
cells. This provides an attractive me-
chanism for the observed increase in
the Treg-specific marker observed in
the periphery of some of our CTCL
patients. In agreement with previous
reports, PBMCs from the three patients,
which were positive for HTLV-1 infec-
tion, exhibited a high level of Foxp3
expression relative to normal indivi-
duals, suggesting a significantly in-
creased proportion of regulatory T
cells in the peripheral blood of these
patients (Figure 1).
These data also point to a strong
association between HTLV-1 and the
induction of a regulatory T-cell pheno-
type. It has recently been demonstrated
that CD4þCD25þ T cells represent
the major reservoir for the HTLV-1
provirus in infected individuals. How-
ever, whether the virus is preferentially
tropic for naturally occurring regulatory
cells or whether infection leads to the
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acquisition of a regulatory phenotype in
nonregulatory CD4þ T cells was not
explicitly addressed (Yamano et al.,
2004). Therefore, we sought to deter-
mine whether HTLV-1 infection of
CD4þCD25 T cells would lead to
the induction of Foxp3 and/or CD25
expression. To this end, CD4þCD25
T cells were purified by FACS from the
peripheral blood of normal healthy
donors (purity497%) and subsequently
cocultured with the irradiated
(10,000 radians (rads)) HTLV-1-infected
MJ cell line using standard techniques
to induce HTLV-1 infection of T cells
(Popovic et al., 1983; Derse et al.,
1995). After 8 weeks of continuous
coculture, approximately 80% of
CD4þ T cells had acquired CD25
expression (Figure 2a and b). These
cells were also HTLV-1 positive by PCR
(Figure 2e). MJ cell line DNA was no
longer detectable (data not shown).
Furthermore, Foxp3 expression in the
CD25þ , HTLV-1-infected cells was
approximately five-fold higher than
observed in otherwise unmanipulated
CD4þCD25 T cells (Figure 2c).
Tumor growth factor (TGF)-b is an
immunosuppressive cytokine, which
plays an important role in the suppres-
sor function of peripherally induced
regulatory T-cell subsets (Th3 cells)
(Chen et al., 1994; Fantini et al.,
2004). The role of TGF-b in the
pathophysiology of CTCL is complex.
Although increased levels of circulating
TGF-b have long been associated with
the immunosuppression observed in
HTLV-1þ CTCL patients, abrogated
TGF-b antiproliferative signaling is as-
sociated with systemic CTCL disease
progression due to a loss of the type II
TGF-b receptor on malignant T cells
(Kadin et al., 1994; Knaus et al., 1996).
However, there is also direct evidence
indicating that HTLV-1 viral proteins
can induce TGF-b expression (Kim
et al., 1990). Therefore, we examined
whether HTLV-1 infection of CD4þ T
cells could enhance TGF-b production
by these cells. Significantly, HTLV-1-
infected CD4þ cells also secreted
higher levels of TGF-b when compared
to CD4þ cells cocultured with a
noninfecting jurkat cell line (Figure 2d).
Together, these data indicate the
acquisition of a regulatory T-cell pheno-
type and provide a potential mechanism
to explain the broad immunosuppres-
sion observed in ATL patients. Similarly,
the finding of enhanced Foxp3 expres-
sion among some patients with HTLV-1-
negative SS also suggests an underlying
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Figure 1. Expression of Foxp3 in PBMCs from normal and CTCL patients. RNA from both patient
(n¼15) and normal PBMC (n¼3) samples were screened for Foxp3 expression by quantitative real-time
RT-PCR. Level of Foxp3 was measured relative to levels of b-actin. Primers were obtained as TaqMan
Gene expression assays with the assay numbers Hs00203958_m1 (FoxP3) and Hs99999903_m1 (b-actin)
(PE Applied Biosystems, Foster City, CA). Foxp3 expression in normal samples was taken as baseline
expression. Results represent mean7standard deviation level of Foxp3 expression in individual samples.
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Figure 2. Induction of a regulatory T-cell phenotype by HTLV-1 infection. (a) Percentage expression
of CD25 on CD4þ T cells after coculture of CD4þCD25 T cells with either irradiated MJ cells
or irradiated Jurkat cells for 8 weeks (n¼ 4). Results expressed as mean7standard deviation.
(b) Representative flow-cytometric analysis from (a) of induction of CD25 expression after 8-week
coculture with irradiated MJ cells. (c) Quantitative real-time PCR analysis of Foxp3 expression on CD4þ
T cells after coculture with the irradiated MJ cell line as in (a) above. Results depict mean7standard
deviation expression level of Foxp3 relative to b-actin under each condition. Data are representative of
four independent experiments with similar results. (d) TGF-b secretion by CD4þ T cells after coculture
with irradiated MJ cells compared to TGF-b secreted by CD4þ T cells cocultured with the non-HTLV-1-
positive jurkat cell line and cultures containing both irradiated cell lines alone. Results represent
mean7standard deviation secretion from four independent coculture experiments. (e) Presence of
HTLV-1 virus in CD4þ T cells after in-vitro coculture with irradiated MJ cell line detected by PCR of viral
genome. Nonirradiated HTLV-1-positive (MJ) and -negative (Jurkat) cell lines used as controls for PCR.
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basis for depressed cellular immunity
among this group of patients. It will be of
interest to determine whether these
Foxp3-positive cells, either derived
from the peripheral blood of CTCL
patients or induced through HTLV-1
infection ex vivo, exhibit a suppressor
T-cell phenotype. Furthermore, these
data suggest that future studies which
focus on counter-regulatory mechan-
isms leading to inhibition of regulatory
T-cell function are likely to yield sub-
stantial therapeutic benefit to patients
with both ATL and SS.
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